SGLT2 inhibitors and cardiac remodelling: a systematic review and meta‐analysis of randomized cardiac magnetic resonance imaging trials

AIMS: Recent large randomized controlled trials (RCTs) have demonstrated efficacy of sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) in both preventing and treating heart failure (HF). SGLT2i‐induced reversal of left ventricular remodelling has been proposed as a mechanism contributing to this ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhingra, Nitish K., Mistry, Nikhil, Puar, Pankaj, Verma, Raj, Anker, Stefan, Mazer, C. David, Verma, Subodh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712921/
https://www.ncbi.nlm.nih.gov/pubmed/34623032
http://dx.doi.org/10.1002/ehf2.13645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712921/
https://www.ncbi.nlm.nih.gov/pubmed/34623032
http://dx.doi.org/10.1002/ehf2.13645

Ejemplares similares